PMR Online Access
Latest reports
Imaging diagnostics market in Poland 2010
Imaging diagnostics market in Central Europe 2010 Dietary supplements market in Romania 2010 Private healthcare market in Poland 2010 Clinical trials in Poland 2010 Distribution on the pharmaceutical market in Central Europe 2010 Private healthcare market in Romania 2010 Distribution on the pharmaceutical market in Poland 2010 In vitro diagnostics market in Poland 2010 Generic and innovative drugs markets in Central and Eastern Europe 2009 see more reports » |
Basic data on pharma in CEETaking into account the pharmaceutical markets of six Central and Eastern European (CEE) countries, Poland is the largest pharmaceutical market in the region. In 2008 the pharmaceutical market in the country (excluding hospital sales) was worth €6.9bn, which represented a 20.3% y-o-y increase in euro terms. It was simultaneously, the most impressive y-o-y change achieved among the six countries analysed. In all six CEE countries the pharmaceutical market grew in 2008 compared to 2007. It should be noted however that in 2007 only the Hungarian market shrank by 2.8% in euro terms.
Pharmaceutical markets of selected Central and Eastern European countries, by sales value and sales volume, 2006-2008 * including hospital sales Note: excluding hospital sales. At retail price level. Source: PMR Publications based on data from: AESGP, IMS Health, PharmaExpert, Cegedim and MASF, 2009 More information about Central and Eastern European pharmaceutical market can be found in: and in PMR pharmaceutical market reports covering Central and Eastern Europe: Diet supplements market Romania 2010 The changes in the lifestyles of Romanians, with healthier diets and bio (health) products becoming more common, have boosted the dietary supplement market in recent years. However, in 2009, mainly as a result of the economic difficulties which the country experienced after the financial meltdown, the growth of the dietary supplement market slowed significantly, increasing by only 1% in final prices in comparison with the previous year, according to PMR’s report: “Dietary supplement market in Romania 2010. Development forecasts for 2010-2013”. Private healthcare market Poland 2010 In 2009 the Polish private healthcare market was worth PLN 27.9bn (€6.4bn), up by ca. 8% on 2008, according to the report by PMR, a research and consulting company, entitled “Private healthcare market in Poland 2010. Development forecasts for 2010-2012”. Despite the economic crisis, which has impeded the rate of growth on the medical subscriptions market in Poland, the leading private medical companies developed their outpatient and inpatient medical services rapidly in 2009. The phenomenon of opening hospitals was new at that time – in the past, those who led the field in sales of medical subscriptions did not operate their own hospitals. Clinical trials Poland 2010 In 2010, the clinical trials market in Poland is expected to grow by 5% year on year, and to reach PLN 718m (€170m), according to the report by PMR, a research and consulting company, entitled “Clinical trials in Poland 2010. Development forecasts for 2010-2012”. If barriers to market growth, including unclear legislation and difficult trial registration procedures at the Central Register of Clinical Trials (the CEBK), were removed, the clinical trials market could develop even more rapidly. Clinical trials Poland 2010 The clinical trials market in Poland slowed in 2009, in comparison with previous years. Between 2006 and 2008, it grew at a rate of 8-10% per annum, whereas 2009 saw a year-on-year increase of only 1%, according to the report by PMR, a research and consulting company, entitled “Clinical trials in Poland 2010. Development forecasts for 2010-2012”. PMR forecasts that in 2010 the market will expand by around 5% year on year and will be worth PLN 718m (€170m). Distribution on the pharmaceutical market in Central Europe 2010 The most important trends and events in distribution in the Central European region in 2009, according to the report by PMR, a research and consulting company, entitled “Distribution on the pharmaceutical market in Central Europe 2010. Comparative analysis of Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria”, were the fall in the number of pharmacies in Poland, the Czech Republic, Hungary and Bulgaria, the consolidation processes among leading Polish wholesalers and the authorisation of the online sale of pharmaceuticals in Slovakia. Private healthcare market Romania 2010 Development of health insurance is expected to take place in the next few years and to begin to take clients from private healthcare providers in the short term. The corporate subscription market is believed to have reached saturation, and some customers might switch in future years to private health insurance, which is believed to be more comprehensive than the services offered by a network of medical facilities. However, this will depend largely on the expansion of private healthcare facilities in the country, according to estimates included in the report “Private healthcare market in Romania 2010. Development forecasts for 2010-2012” by PMR, a research and consulting company. Distribution on the pharmaceutical market in Poland 2010 According to the report by the research and consulting company PMR, “Distribution on the pharmaceutical market in Poland 2010. Development forecasts for 2010-2012”, during the period 2008-2009 the pharmaceutical distribution sector in Poland saw further consolidation, both among distributors and among retailers. The most important event in the wholesale distribution segment was the buyout of Prosper by Torfarm, another leading distributor on the Polish market, in April 2009. After the fusion, the two companies together control more than 30% of the market of distribution to pharmacies in Poland. In vitro diagnostics market in Poland 2010 Generic and innovative drugs markets in Central and Eastern Europe 2009 OTC market in Central and Eastern Europe 2009 Biotechnological innovations in the pharmaceutical industry in Poland 2009 Pharmaceutical and healthcare market in Poland 2009 Private healthcare market in Poland 2009 Private healthcare market in Central and Eastern Europe 2009 to see all PMR pharmaceutical market reports visit PMR Publications on-line shop. If you would like to learn more about PMR business solutions in Central and Eastern European countries please visit below mentioned PMR websites: PMR Consulting to learn more about our consulting services PMR Research to learn more about our market research services PMR Publications to learn more about our market intelligence publications If you would like to learn more about PMR please visit PMR Corporate website. |
Free headlines |
Copyright © 2010 PMR. All rights reserved.
PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.